Diagnosis and inflammation monitoring - Insights
Patients with symptoms that arouse clinical suspicion of either inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) are both common and tough to differentiate.
Learn more about how Mayo Clinic Laboratories’ genetic testing for pulmonary conditions can provide diagnostic confirmation for an array of inherited illnesses.
Exploratory testing - Insights
Mayo Clinic Laboratories’ whole exome and whole genome sequencing assays provide in-depth interrogation of all the genes in the human genome, offering individualized insights for optimal outcomes.
Learn more about how immunology testing at Mayo Clinic Laboratories can reveal genetic associations to disorders that impact the immune system.
Cholesterol biosynthesis and transport - Insights
Check out Mayo Clinic Laboratories’ testing approach to diagnose disorders related to cholesterol biosynthesis and transport.
Research collaborations - Insights
Find out about setting up a contract with Mayo Clinic, analytical validation, the role of the institutional review board, and how your data will be handled.
Invasive fungal infection - Insights
Mayo Clinic Laboratories’ fungal biomarker test rapidly screens for invasive fungal infections caused by various fungal pathogens.
Histoplasma/Blastomyces - Insights
Mayo Clinic Laboratories full menu of testing for Histoplasma or Blastomyces infection includes an innovative, direct detection assay can detect antigens from both species.
Ova and parasite testing - Insights
Learn about our ova and parasite test and its role as a fundamental laboratory method to detect parasitic helminths and protozoa in stool specimens.
Commercial laboratories partners have access to Mayo Clinic Laboratories full menu of subspecialty testing, which spans the spectrum of medical specialties.
Including carrier screening, molecular testing, and cytogenetic analysis, Mayo Clinic Laboratories prenatal evaluations provide vital insights for prospective and expecting parents.
Thiopurine Management Testing for IBD - Mayo Clinic Laboratories
Thiopurine management is important because it can detect individuals with low thiopurinemethyltransferase (TPMT) activity who are at risk for excessive myelosuppression or severe hematopoietic toxicity when taking thiopurine drugs.
Genetic liver disease - Insights
Identifying underlying genetic disorders plays an important role in the treatment and care of patients with liver disease. Appropriate use of screening tests in routine clinical practice can rule out possible causes of liver disease and...
For children who require thiopurine medications (such as azathioprine and 6-mercaptopurine) to treat inflammatory bowel disease (IBD), understanding how thiopurines are metabolized is vital to choosing the most effective treatment. Because...
Viral Hepatitis Testing - Mayo Clinic Laboratories
At Mayo Clinic, we utilize an algorithmic approach to testing that takes the guesswork out of test ordering to focus on proper test utilization, saving your institution time and money.
Mosquito-borne disease - Insights
View our comprehensive menu of individually orderable tests and panels for mosquito-borne diseases and our algorithmic approach to testing.
Neurodevelopmental disorders - Insights
Learn more about how chromosomal microarray can be used as a first-tier diagnostic test for those with congenital abnormalities and developmental disabilities.
Comprehensive urine drug profiles - Insights
Mayo Clinic Laboratories’ comprehensive controlled substance monitoring profiles use multiple methodologies to detect the lowest levels of substances.
Learn more about how Mayo Clinic Laboratories’ targeted, high-resolution screening panel for stimulant use identifies and confirms the presence of 10 stimulants and phencyclidine (PCP) with a single test.
Chain of custody drug testing - Insights
Chain of custody testing at Mayo Clinic Laboratories is performed on urine, serum, and meconium and adheres to the highest quality standards to provide secure results.
Comprehensive drug urine profiles - Insights
Able to detect 22 drug classes, our comprehensive addiction medicine profile can help identify polysubstance use disorder as well as assess and manage patients at risk for substance use disorder.
Therapeutic drug monitoring - Insights
Learn more about Mayo Clinic Laboratories’ clinically driven approach to therapeutic drug monitoring.
Urine supersaturation testing - Insights
Find out how our kidney stone testing services can predict the likely composition of stones in patients for whom stone analysis is not available.
Learn how the pulmonary pathology section at Mayo Clinic Laboratories can provide second-opinion consultations on a broad range of neoplastic and nonneoplastic thoracic cases, including primary ciliary dyskinesia.
Check out Mayo Clinic Laboratories’ full menu of testing for individual drug classes, including benzodiazepines, stimulants, opioids, alcohol, and more.
Learn more Mayo Clinic Laboratories robust menu of newborn screening testing, which includes both primary and second-tier biochemical and molecular evaluations.
Next-generation sequencing - Insights
Browse our comprehensive next-generation sequencing test menu for patients who have bleeding and thrombosis disorders.
Minimal residual disease - Insights
Get full-spectrum minimal residual disease testing options, all from one laboratory, with experts to support testing decisions and results.
Gynecological cancer - Insights
Find out how our gynecological cancer panels evaluate genes with relevance to diagnosing and treating uterine, ovarian, and endometrial cancers.
Neuropathies - Mayo Clinic Laboratories
Our comprehensive approach evaluates specific antibodies associated with autoimmune or paraneoplastic neuropathies offering answers for patients.
CNS Demyelinating Disease Testing - Mayo Clinic Laboratories
We offer the only FACS assay for CNS Demyelinating Disease. Our testing ensures the highest senstivity and specificity, providing the most accurate results for patients.
Colorectal Cancer NGS Testing - Mayo Clinic Laboratories
Our panel was designed to meet current guidelines and remain targeted enough to provide clinically actionable results.
Benign Hematology Testing - Mayo Clinic Laboratories
Our metabolic hematology laboratory is dedicated to providing accurate diagnoses and interpretations with an emphasis on clinical significance for your patients.
Learn about our full suite of leukemia testing protocols, including includes flow cytometry, chromosome, FISH, and molecular testing.
Acute Myeloid Leukemia Testing - Mayo Clinic Laboratories
Find out how our clinically validated testing for acute myeloid leukemia can provide critical diagnostic, prognostic, and therapeutic information for physicians.
Neuromuscular disorders - Insights
Learn more about our specialized testing for neuromuscular diseases, including myasthenia gravis, Lambert-Eaton syndrome, and more.
Colorectal and GI Cancer Testing - Mayo Clinic Laboratories
The results and interpretations from our laboratories provide clinically actionable results to guide treatment selection, ensuring every patient receives the medication most appropriate for care.
Breast and Gynecological Cancer - Insights
Learn how our gynecological cancer and breast cancer treatment tests are designed to provide a detailed picture of a patient’s cancer diagnosis.
Muscle and nerve biopsy consultation - Insights
Our experienced muscle and nerve specialists apply their knowledge to correlate pathological findings with clinical presentation and other testing to confirm specific neuromuscular diseases.
Mitochondrial disease - Insights
Learn about our four molecular testing options, which can be used to confirm a diagnosis and identify a specific mitochondrial syndrome.
Hereditary neuromuscular disorders - Insights
Find out how our distinctive approach to evaluating for inherited neuromuscular disorders uses phenotypic information to streamline diagnosis.
B-cell and T-cell acute lymphoblastic leukemia - Insights
Find out how our suite of B-cell and T-cell acute lymphoblastic leukemia tests can detect genetic subgroups and assist in treatment selection.
Find out more about UBA1Q, a quantitative droplet digital polymerase chain reaction (ddPCR) assay that targets seven possible mutations that can occur in the UBA1 gene and help identify VEXAS syndrome.
Browse our full menu of testing for motor and sensory neuropathies, spastic paraplegia, amyloidosis, and brachial plexus, among other conditions.
Testing Archives - Page 24 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 23 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Appropriate Use of Gastrointestinal Pathogen Panel by PCR [Utilization Spotlight] - Insights
Infectious diarrhea is a common and usually self-limited illness. While most patients with infectious causes of diarrhea will get better on their own, there are certain scenarios in which testing is indicated. The The FilmArray...
Lysosomal Storage Disease Panel by NGS [Test in Focus] - Insights
Devin Oglesbee, Ph.D., Director of the Biochemical and Molecular Genetics Laboratories at Mayo Clinic, provides an overview of the lysosomal storage disease panel, when it is appropriate to order this test, what actions the results allow...
Testing Archives - Page 8 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...
Testing Archives - Page 9 of 26 - Insights
Skip to Content MayoACCESS MayoLINK...